Alpha BreakingAlpha Breaking
Bearish Sentiment

Here’s What Hurt Conocophillips’ COP in Q2 - Jul 14

6 min readTuesday, July 14, 2026 at 11:02 AM ET
Here’s What Hurt Conocophillips’ COP in Q2 - Jul 14

Share this article

Spread the word on social media

The Big Picture

Oakmark's latest investor letter pulled no punches: ConocoPhillips stood out as a meaningful drag on the Oakmark Fund in Q2, and that shortfall showed up in the fund's performance versus the benchmark. The gap matters for investors tracking energy exposure or larger-cap value allocations, because a single holding can sway active-fund returns in a quarter where the index moved sharply higher.

Yahoo Finance's summary of the Harris Oakmark letter makes clear the investor-class performance trailed the S&P 500 in Q2, and the letter calls out $COP among the holdings that hurt results.

What's Happening

Harris Oakmark published its second-quarter 2026 investor letter for the Oakmark Fund, and the update highlighted specific figures that investors should parse closely. The fund's investor-class return lagged the wider market, and the write-up identifies ConocoPhillips as a contributor to that underperformance.

  • 3.07% — reported investor-class return for the Oakmark Fund in Q2, per the letter summary.
  • 9% — the S&P 500's gain in the same period, used in the letter as the comparative benchmark.
  • 1.52% — cited in the update as a notable figure tied to the performance impact, pointing to a meaningful single-stock drag.
  • 0.01% — a small net contribution figure also listed in the update, indicating that other holdings largely offset each other.

Those numbers tell a compact story: Oakmark's investor-class return of 3.07% fell well short of the S&P 500's roughly 9% rise. The letter singles out $COP as one of the positions that hurt relative performance, and the 1.52% figure in the update signals that ConocoPhillips' influence was large enough to matter at the fund level.

Why It Matters For Your Portfolio

If you hold $COP directly or own funds that track Harris Oakmark's positioning, this update is relevant because it highlights how a single energy position can swing quarterly results. Growth and value investors will read this differently: value-oriented managers may still favor $COP on longer-term fundamentals, while growth investors will note how cyclical energy names can hurt short-term performance.

Analysts and active managers are clearly watching positions that drove the Oakmark Fund's quarter; recent analyst activity suggests Wall Street attention on names that influenced relative returns. For multi-asset and concentrated portfolios, a roughly 1.5% single-stock impact is large enough to warrant re-examining position sizing and risk assumptions.

Risks To Consider

  • Concentration risk: a single large holding like $COP can materially affect fund-level returns, increasing short-term volatility for concentrated portfolios.
  • Commodity and cyclical exposure: energy names remain tied to oil and gas price swings, which can turn performance quickly in either direction.
  • Execution and operational risk: if operational setbacks or capital allocation moves hit $COP, the negative impact can extend beyond one quarter and affect valuation assumptions.

What To Watch Next

Investors should track near-term company and market catalysts that could change the narrative for $COP and for funds holding it. These are the items to monitor closely.

  • Company releases and quarterly updates, including any additional commentary in investor letters or earnings calls that clarify why $COP was a detractor.
  • Oil and gas price moves, which remain a key driver of energy-sector earnings and cash flow variability.
  • Portfolio rebalancing or position-size changes by large active managers, which can shift demand for $COP shares and related sector names.

The Bottom Line

  • Harris Oakmark's Q2 investor letter shows the Oakmark Fund returned 3.07% for investor-class shares, trailing the S&P 500's roughly 9% rise.
  • ConocoPhillips ($COP) was explicitly highlighted as a material detractor, tied to a roughly 1.52% performance impact in the update.
  • That single-stock influence underscores the importance of position sizing for active funds and concentrated portfolios.
  • Watch upcoming company commentary, commodity price swings, and manager rebalancing for signs the situation is changing.
  • Data suggests reviewing exposure and risk tolerance is prudent if $COP or similarly sized energy holdings form a large share of your portfolio.

FAQ

Q: Did ConocoPhillips Cause Oakmark's Underperformance?

A: The Harris Oakmark letter singled out ConocoPhillips as a holding that hurt the Oakmark Fund in Q2; the update links a roughly 1.52% performance impact to that effect, contributing to the fund's 3.07% return versus the S&P 500's roughly 9% gain.

Q: Should I change my $COP exposure after this update?

A: The letter highlights the short-term impact of $COP on Oakmark's returns but does not provide investment advice. Investors should reassess position size against their own risk tolerance and the broader exposure to commodity cycles.

Q: What are the immediate indicators that could reverse this trend?

A: Monitor ConocoPhillips' corporate updates, oil and gas price moves, and any portfolio adjustments from major active managers, as those factors could shift $COP's impact on fund performance.

Here’s What Hurt ConocoPhillips’ (COP) in Q2ConocoPhillips Q2COP Q2ConocoPhillips performanceOakmark Fund Q2

Trade this headline in Alpha Contests.

Free practice contests — earn Alpha Coins
Enter a Contest

Stay Ahead of the Market

Get breaking news on trending finance topics delivered as they happen. We find the stories others miss.

More Breaking News

Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.